A multicenter, randomized, open label comparative study of azithromycin extended release (Zmax) versus amoxicillin/clavulanate potassium [clavulanic acid] in subjects with acute bacterial sinusitis (ABS) in a physician practice environment

Trial Profile

A multicenter, randomized, open label comparative study of azithromycin extended release (Zmax) versus amoxicillin/clavulanate potassium [clavulanic acid] in subjects with acute bacterial sinusitis (ABS) in a physician practice environment

Completed
Phase of Trial: Phase IV

Latest Information Update: 24 Mar 2010

At a glance

  • Drugs Amoxicillin/clavulanic acid; Azithromycin
  • Indications Acute sinusitis; Bacterial infections
  • Focus Therapeutic Use
  • Sponsors Pfizer
  • Most Recent Events

    • 24 Mar 2010 Patient numbers amended from 749 to 762 as reported by ClinicalTrials.gov.
    • 01 Feb 2010 Results published in the American Journal of Otolaryngology - Head and Neck Medicine and Surgery.
    • 20 Sep 2007 Status change from in progress to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top